Citation: | Zeng Weisheng, Li Zhen, Song Mi, et al. Clinical analysis of the influence of gender on blood concentration of mycophenolic acid in recipients undergoing renal transplantation[J]. ORGAN TRANSPLANTATION, 2018, 9(5): 385-389. doi: 10.3969/j.issn.1674-7445.2018.05.011 |
[1] |
THURET R, KLEINCLAUSS F, TERRIER N, et al.Challenges in renal transplantation[J].Prog Urol, 2016, 26(15):1001-1044.DOI: 10.1016/j.purol.2016.09.056.
|
[2] |
FETURI FG, WEINSTOCK M, ZHAO W, et al.Mycophenolic acid for topical immunosuppression in vascularized composite allotransplantation:optimizing formulation and preliminary evaluation of bioavailability and pharmacokinetics[J].Front Surg, 2018, 5:20.DOI: 10.3389/fsurg.2018.00020.
|
[3] |
SLOVAK JE, RIVERA SM, HWANG JK, et al.Pharmacokinetics of mycophenolic acid after intravenous administration of mycophenolate mofetil to healthy cats[J].J Vet Intern Med, 2017, 31(6):1827-1832.DOI: 10.1111/jvim.14827.
|
[4] |
ZHANG D, CHOW DS.Clinical pharmacokinetics of mycophenolic acid in hematopoietic stem cell transplantation recipients[J].Eur J Drug Metab Pharmacokinet, 2017, 42(2):183-189.DOI: 10.1007/s13318-016-0378-6.
|
[5] |
RUSCHEL LR, SCHMITT VM, SILVA AB, et al.Study on the association of UGT1A9 gene c.98T > C polymorphism and mycophenolic acid plasma levels in renal transplant patients[J].Genet Mol Res, 2017, 16(2).DOI: 10.4238/gmr16029598.
|
[6] |
李朋梅, 张相林, 唐崑, 等.人血浆中霉酚酸浓度测定方法研究及药物监测应用[J].中国药学杂志, 2007, 42(19):1490-1493.DOI:10.3321/j.issn:1001- 2494.2007.19.015.
LI PM, ZHANG XL, TANG K, et al.Determination of mycophenolic acid concentration in human plasma and its application to therapeutic drug monitoring in renal transplantation patient[J].Chin Pharm J, 2007, 42(19):1490-1493.DOI: 10.3321/j.issn:1001-2494.2007.19.015.
|
[7] |
JEONG H, KAPLAN B.Therapeutic monitoring of mycophenolate mofetil[J].Clin J Am Soc Nephrol, 2007, 2(1):184-191. doi: 10.1097-01.tp.0000186380.61251.fc/
|
[8] |
MATHEW BS, FLEMING DH, ANNAPANDIAN VM, et al.A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period[J].Ther Drug Monit, 2010, 32(2):136-140.DOI: 10.1097/FTD.0b013e3181cd550f.
|
[9] |
JIA Y, PENG B, LI L, et al.Estimation of mycophenolic acid area under the curve with limited-sampling strategy in Chinese renal transplant recipients receiving enteric-coated mycophenolate sodium[J].Ther Drug Monit, 2017, 39(1):29-36.DOI: 10.1097/FTD.0000000000000360.
|
[10] |
LIU W, KULKARNI K, HU M.Gender-dependent differences in uridine 5'-diphospho-glucuronosyltransferase have implications in metabolism and clearance of xenobiotics[J].Expert Opin Drug Metab Toxicol, 2013, 9(12):1555-1569.DOI: 10.1517/17425255.2013.829040.
|
[11] |
WU B, KULKARNI K, BASU S, et al.First-pass metabolism via UDP-glucuronosyltransferase:a barrier to oral bioavailability of phenolics[J].J Pharm Sci, 2011, 100(9):3655-3681.DOI: 10.1002/jps.22568.
|
[12] |
谢晓纯, 王洪阳, 李嘉丽, 等.性别对肾移植患者霉酚酸酯药代动力学影响的研究[J].中国临床药理学杂志, 2015, 31(6):456-458, 462.DOI: 10.13699/j.cnki.1001-6821.2015.06.017.
XIE XC, WANG HY, LI JL, et al.Influence of gender on mycophenolate mofetil pharmacokinetics in Chinese renal transplant patients[J].Chin J Clin Pharmacol, 2015, 31(6):456-458, 462.DOI: 10.13699/j.cnki.1001-6821.2015.06.017.
|
[13] |
张丽娟, 陈璐, 朱宇轩, 等.有限采样法用于肾移植受者霉酚酸酯血药浓度监测的分析[J].中国生化药物杂志, 2016, 36(7):187-190.DOI:10.3969/j.issn.1005- 1678.2016.07.57.
ZHANG LJ, CHEN L, ZHU YX, et al.Use of limited sampling strategy to analyse MMF blood concentration in renal transplant recipients[J].Chin J Biochem Pharmac, 2016, 36(7):187-190.DOI: 10.3969/j.issn.1005-1678.2016.07.57.
|
[14] |
WOILLARD JB, REROLLE JP, PICARD N, et al.Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil:the significant role of the UGT1A8 2 variant allele[J].Br J Clin Pharmacol, 2010, 69(6):675-683.DOI: 10.1111/j.1365-2125.2010.03625.x.
|
[15] |
ALVAREZ-ELÍAS AC, YOO EC, TODOROVA EK, et al.A retrospective study on mycophenolic acid drug interactions:effect of prednisone, sirolimus, and tacrolimus with MPA[J].Ther Drug Monit, 2017, 39(3):220-228.DOI: 10.1097/FTD.0000000000000403.
|